Innovative | Pharma Marketer

NEJM spotlights Provenge study

Thursday, July 29th, 2010

Shares of Dendreon ( NASDAQ: DNDN ) soared into the stratosphere in the lead-up to Provenge’s approval–and then promptly started tumbling fast as all sorts of questions arose about supply issues, cost

Posted in: Pharma News | 0 Comments »

Read the full story

Genentech licenses UK package of small molecule drugs

Monday, July 12th, 2010

London-based MRC Technology has inked a licensing pact with Genentech for a package of small molecule drug candidates for neurological conditions. MRC gets an unspecified upfront payment along with a slate of potential milestones for the licensing deal, the first major small molecule collaboration MRC has struck for its Centre for Therapeutics Discovery

Posted in: Pharma News | 0 Comments »

Read the full story

Basilea sees another ceftobiprole rejection, isavuconazole delay

Friday, June 25th, 2010

Swiss biotech Basilea Pharmaceutica saw its shares decline Friday after the European Committee for Medicinal Products for Human Use confirmed its previous negative opinion on the marketing authorization application for ceftobiprole to treat complicated skin and soft tissue infections. The news comes as Basilea’s Japanese partner Astellas Pharma said it was expanding a late-stage trial of the antifungal isavuconazole, delaying the release of data up to 18 months.

Posted in: Pharma News | 0 Comments »

Read the full story

Teva’s ALS drug flunks a Phase II trial

Tuesday, May 18th, 2010

Teva Pharmaceuticals’ experimental therapy for Lou Gehrig’s disease failed a mid-stage clinical trial. Researchers said that its amyotrophic lateral sclerosis drug talampanel failed to hit the primary endpoint for a reduction in disease-related functional deterioration

Posted in: Pharma News | 0 Comments »

Read the full story

Sanofi chops 70 jobs in Canada

Wednesday, May 5th, 2010

To underscore its complaints that the Canadian government is allowing generic competition to encroach on markets for products still under patent protection, Sanofi-Aventis announced that it is cutting 70 positions out of its operations there.

Posted in: Pharma News | 0 Comments »

Read the full story

Pay as you live health models ?

Friday, December 11th, 2009

At Safeway employees are tested for the four measures cited above and receive premium discounts off a “base level” premium for each test they pass. Data is collected by outside parties and not shared with company management.

Posted in: DTC | 0 Comments »

Read the full story

Bondronat

Monday, August 3rd, 2009

Biophosphonate therapy… Time for a change? New 15 minute infusion time IV initiation, Oral maintenance Brand name: Bondronat Generic name/category: Ibandronic acid, Bisphosphonates Company: Roche Country/Market: UK, Europe Indication(s)/use: prevention and treatment of osteoporosis Target: Healthcare Professionals (HCP) Tagline: Innovative, multi-targeted bone protection Publication: 2009 To see all of the ads from this campaign, click here To see all of this brand’s ads on AdPharm, click here

Posted in: Pharma Ads | 0 Comments »

Read the full story

Pay as you live health model

Saturday, June 13th, 2009

At Safeway employees are tested for the four measures cited above and receive premium discounts off a “base level” premium for each test they pass. … If they pass all four tests, annual premiums are reduced $780 for individuals and $1,560 for families.

Posted in: DTC | 0 Comments »

Read the full story

A fitness trainer’s great Business Card

Friday, May 8th, 2009

Lose your flab Objective Design a business card for fitness trainer Zohra Mouhetta that complements the effectiveness of her personal training programmes and makes for a memorable had out to prospective clients. Concept In order to stand out from all the leave-behinds people receive every day, we designed a unique, foldable business card that invites the recipient to intereact with it and clearly demonstrates what personal fitness training can do for the body. Outcome The number of inquiries and sign-ups, including corporate clientys, increased substantially within a month

Posted in: Pharma Ads | 0 Comments »

Read the full story